Statistics for Machine learning-based virtual screening, molecular docking, drug-likeness, pharmacokinetics and toxicity analyses to identify new natural inhibitors of the glycoprotein spike (S1) od SARS-CoV-2
Total visits
| views | |
|---|---|
| Machine learning-based virtual screening, molecular docking, drug-likeness, pharmacokinetics and toxicity analyses to identify new natural inhibitors of the glycoprotein spike (S1) od SARS-CoV-2 | 48 |
Total visits per month
| views | |
|---|---|
| January 2025 | 1 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
File Visits
| views | |
|---|---|
| null(legacy) | 31 |
| Machine learning-based virtual screening, molecular docking, drug-likeness, pharmacokinetics and toxicity analyses to identify new natural inhibitors of the glycoprotein spike (S1) od SARS-CoV-2.pdf(legacy) | 8 |
| Machine learning-based virtual screening, molecular docking, drug-likeness, pharmacokinetics and toxicity analyses to identify new natural inhibitors of the glycoprotein spike (S1) od SARS-CoV-2.pdf | 3 |
Top country views
| views | |
|---|---|
| United States | 10 |
| United Kingdom | 6 |
| Portugal | 6 |
| China | 4 |
| India | 4 |
| South Korea | 4 |
| Brazil | 3 |
| Singapore | 3 |
| Australia | 1 |
| Algeria | 1 |
| France | 1 |
| Iran | 1 |
| Japan | 1 |
| Malaysia | 1 |
| Russia | 1 |
| Ukraine | 1 |
Top city views
| views | |
|---|---|
| Alagoinhas | 1 |